Real-time enrollment status for this bladder cancer clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 7:45 PM UTC
| NCT Number | NCT06833073 |
| Recruiting Status | Recruiting |
| Condition | Bladder Cancer |
| Phase | PHASE2 |
| Target Enrollment | 308 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | July 2, 2026 (2 weeks ago) |
As of July 16, 2026: Clinical trial NCT06833073 is currently recruiting participants. This phase2 study for bladder cancer is actively seeking new participants at 20 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06833073 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06833073 was last updated 2 weeks ago (July 2, 2026). HelloStudys verifies this status automatically.